NCT06768411View on ClinicalTrials.gov

The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children

NANot yet recruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

June 1, 2027

Conditions

Short Stature

Interventions

DRUG

PEG-rhGH

1= 0.2mg/kg/week Initial doses of PEG-rhGH 2=0.22mg/kg/week Initial doses of PEG-rhGH

DRUG

GnRHa

"1. pubertal children of short stature without GnRHa treatment~2. pubertal children of short stature with GnRHa treatment"

All Listed Sponsors

lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT06768411 - The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children | Biotech Hunter | Biotech Hunter